Cargando…

Inducible Mouse Models for Cancer Drug Target Validation

Genetically-engineered mouse (GEM) models have provided significant contributions to our understanding of cancer biology and developing anticancer therapeutic strategies. The development of GEM models that faithfully recapitulate histopathological and clinical features of human cancers is one of the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jeong, Joseph H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Cancer Prevention 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207608/ https://www.ncbi.nlm.nih.gov/pubmed/28053958 http://dx.doi.org/10.15430/JCP.2016.21.4.243

Ejemplares similares

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer
por: Wittwer, Nicole L, et al.
Publicado: (2023)

Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
por: Moustaqil, Mehdi, et al.
Publicado: (2020)

Tumor-related interleukins: old validated targets for new anti-cancer drug development
por: Setrerrahmane, Sarra, et al.
Publicado: (2017)

Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug
por: Chen, Yinhsuan Michely, et al.
Publicado: (2020)

ICR suckling mouse model of Zika virus infection for disease modeling and drug validation
por: Wu, Yu-Hsuan, et al.
Publicado: (2018)

Mouse models of colorectal cancer
por: Tong, Yunguang, et al.
Publicado: (2011)

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
por: Baandrup Kristiansen, Maria Nicoline, et al.
Publicado: (2019)

A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models
por: Sim, Yun Hee, et al.
Publicado: (2022)

Genomic approaches to drug target discovery using mouse models
por: Morris, DW
Publicado: (2003)

Cancer Metabolism: New Validated Targets for Drug Discovery
por: Sotgia, Federica, et al.
Publicado: (2013)

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
por: Gabaldón-Figueira, Juan Carlos, et al.
Publicado: (2023)

Drug discovery oncology in a mouse: concepts, models and limitations
por: Long, Jason E, et al.
Publicado: (2021)

Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?
por: Rosas-Cruz, Arely, et al.
Publicado: (2021)

Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)

Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model
por: Hajdin, Katarina, et al.
Publicado: (2010)

Mouse model phenotypes provide information about human drug targets
por: Hoehndorf, Robert, et al.
Publicado: (2014)

Mouse Models of Gastric Cancer
por: Hayakawa, Yoku, et al.
Publicado: (2013)

Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
por: Yang, Liu, et al.
Publicado: (2021)

Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
por: Huijbers, Ivo J, et al.
Publicado: (2014)

Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer
por: Rajput, Ashwani, et al.
Publicado: (2013)

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies
por: Andrechek, Eran R., et al.
Publicado: (2010)

Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment
por: Karnik, Isha, et al.
Publicado: (2023)

Diabetic neuropathy research: from mouse models to targets for treatment
por: Pham, Vuong M., et al.
Publicado: (2019)

Revisiting the mouse model of oxygen-induced retinopathy
por: Kim, Clifford B, et al.
Publicado: (2016)

Glucose-6-Phosphate Dehydrogenase of Trypanosomatids: Characterization, Target Validation, and Drug Discovery
por: Gupta, Shreedhara, et al.
Publicado: (2011)

Advances in TRP channel drug discovery: from target validation to clinical studies
por: Koivisto, Ari-Pekka, et al.
Publicado: (2021)

Chromatin targeting drugs in cancer and immunity
por: Prinjha, Rab, et al.
Publicado: (2013)

Glycans as Targets for Drug Delivery in Cancer
por: Diniz, Francisca, et al.
Publicado: (2022)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
por: Verhulst, Emile, et al.
Publicado: (2022)

Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
por: Lee, Ho
Publicado: (2014)

The role of mouse tumour models in the discovery and development of anticancer drugs
por: Ireson, Christopher R., et al.
Publicado: (2019)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model
por: Li, Rui, et al.
Publicado: (2020)

Mouse models of breast cancer metastasis
por: Fantozzi, Anna, et al.
Publicado: (2006)

Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms()
por: Chen, Qingfeng, et al.
Publicado: (2019)

Mouse models for hepatitis B virus research
por: Hwang, Jeong-Ryul, et al.
Publicado: (2018)

Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible
por: HWANG, Young Sun, et al.
Publicado: (2015)

Mouse Models of Prostate Cancer
por: Valkenburg, Kenneth C., et al.
Publicado: (2011)

Mouse models of intestinal cancer
por: Jackstadt, Rene, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aqf2i5go872fsr49od6shgbnja